Labcorp Holdings Inc. (LH) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es Schechter Adam H con 113,137 acciones. Otros tenedores destacados incluyen EISENBERG GLENN A y Caveney Brian J.
En los últimos 12 meses, los internos han realizado 121 transacciones en LH acciones — 24 compras (valoradas en $2.22M) y 19 ventas (valoradas en $13.16M). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.
LH Participación de Insiders
Principal Titular
Schechter Adam H
113,137 acciones
Compras (12 meses)
24
$2.22M valor
Ventas (12 meses)
19
$13.16M valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Schechter Adam H |
President & CEO |
113,137 |
2026-03-30 |
|
| 2 |
Eisenberg Glenn A |
Executive Vice President |
37,920 |
2025-03-31 |
|
| 3 |
Caveney Brian J |
EVP, Pres of Ed, CMO & CSO |
35,369 |
2026-03-30 |
|
| 4 |
Berberian Lance |
EVP, Special Advisor, Strategy |
18,652 |
2025-03-31 |
|
| 5 |
Pike Thomas |
Pres & CEO Clinical Business |
16,960 |
2023-01-11 |
|
| 6 |
Kirchgraber Paul R |
CEO, Covance Drug Development |
12,946 |
2023-04-03 |
|
| 7 |
Schroeder Mark S |
EVP, Pres Diagnostics & COO |
11,177 |
2026-03-30 |
|
| 8 |
Summy Amy B. |
EVP, Chief Marketing Officer |
7,880 |
2026-03-30 |
|
| 9 |
Vaughn Bryan T |
EVP, Diagnostics |
6,746 |
2026-03-30 |
|
| 10 |
Gilliland Dwight Gary |
Director |
6,656 |
2025-08-01 |
|
| 11 |
Van Der Vaart Sandra D |
EVP, Corporate Affairs |
6,239 |
2026-03-30 |
|
| 12 |
Graham Anita Z |
EVP, Chro |
5,185 |
2026-03-30 |
|
| 13 |
Oyegunwa Akinbolade |
EVP, CIO & CTO |
5,064 |
2026-03-30 |
|
| 14 |
Bailey Megan D. |
EVP, Pres, Central Labs & Intl |
4,851 |
2026-03-30 |
|
| 15 |
Kyle Kathryn W |
EVP, Chief Legal Officer |
4,575 |
2026-03-30 |
|
| 16 |
Meltzer Jonathan C |
EVP, Operations |
4,459 |
2026-03-30 |
|
| 17 |
Seltz Judith C |
EVP, Chro |
4,182 |
2023-04-03 |
|
| 18 |
Wilkinson Peter J |
SVP, Chief Accounting Officer |
3,485 |
2026-03-30 |
|
| 19 |
Divincenzo Jonathan P. |
EVP, Pres, Central Labs & Intl |
1,965 |
2024-03-29 |
|
| 20 |
Wang Julia Aijun |
Chief Financial Officer, EVP |
1,817 |
2026-02-13 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2026-03-26 |
Vaughn Bryan T |
EVP, Diagnostics |
Retención Fiscal de RSU |
451 |
$268.38 |
$121.04K |
| 2026-03-27 |
Meltzer Jonathan C |
EVP, Operations |
Venta Informativa |
839 |
$267.05 |
$224.05K |
| 2026-03-26 |
Meltzer Jonathan C |
EVP, Operations |
Retención Fiscal de RSU |
711 |
$268.38 |
$190.82K |
| 2026-03-26 |
Kyle Kathryn W |
EVP, Chief Legal Officer |
Retención Fiscal de RSU |
451 |
$268.38 |
$121.04K |
| 2026-03-26 |
Oyegunwa Akinbolade |
EVP, CIO & CTO |
Retención Fiscal de RSU |
382 |
$268.38 |
$102.52K |
| 2026-03-26 |
Bailey Megan D. |
EVP, Pres, Central Labs & Intl |
Retención Fiscal de RSU |
481 |
$268.38 |
$129.09K |
| 2026-03-26 |
Summy Amy B. |
EVP, Chief Marketing Officer |
Retención Fiscal de RSU |
1,836 |
$268.38 |
$492.75K |
| 2026-03-26 |
Schroeder Mark S |
EVP, Pres Diagnostics & COO |
Retención Fiscal de RSU |
4,600 |
$268.38 |
$1.23M |
| 2026-03-26 |
Caveney Brian J |
EVP, Pres of Ed, CMO & CSO |
Retención Fiscal de RSU |
4,042 |
$268.38 |
$1.08M |
| 2026-03-26 |
Van Der Vaart Sandra D |
EVP, Corporate Affairs |
Retención Fiscal de RSU |
2,722 |
$268.38 |
$730.53K |
| 2026-03-27 |
Wilkinson Peter J |
SVP, Chief Accounting Officer |
Venta Informativa |
1,633 |
$267.05 |
$436.09K |
| 2026-03-26 |
Wilkinson Peter J |
SVP, Chief Accounting Officer |
Retención Fiscal de RSU |
755 |
$268.38 |
$202.63K |
| 2026-03-26 |
Schechter Adam H |
President & CEO |
Retención Fiscal de RSU |
26,106 |
$268.38 |
$7.01M |
| 2026-03-26 |
Graham Anita Z |
EVP, Chro |
Retención Fiscal de RSU |
2,879 |
$268.38 |
$772.67K |
| 2026-03-03 |
Schechter Adam H |
President & CEO |
Venta Informativa |
8,705 |
$279.96 |
$2.44M |
| 2026-02-27 |
Van Der Vaart Sandra D |
EVP, Corporate Affairs |
Venta Informativa |
548 |
$284.91 |
$156.13K |
| 2026-02-24 |
Caveney Brian J |
EVP, Pres of Ed, CMO & CSO |
Venta Informativa |
1,500 |
$286.31 |
$429.46K |
| 2026-02-19 |
Wilkinson Peter J |
SVP, Chief Accounting Officer |
Venta Informativa |
666 |
$277.94 |
$185.11K |
| 2026-02-11 |
Vaughn Bryan T |
EVP, Diagnostics |
Ejercicio de Opciones (Venta) |
323 |
- |
- |
| 2026-02-12 |
Meltzer Jonathan C |
EVP, Operations |
Venta Informativa |
87 |
$290.42 |
$25.27K |
| 2026-02-11 |
Meltzer Jonathan C |
EVP, Operations |
Ejercicio de Opciones (Venta) |
243 |
- |
- |
| 2026-02-11 |
Kyle Kathryn W |
EVP, Chief Legal Officer |
Ejercicio de Opciones (Venta) |
216 |
- |
- |
| 2026-02-11 |
Oyegunwa Akinbolade |
EVP, CIO & CTO |
Ejercicio de Opciones (Venta) |
230 |
- |
- |
| 2026-02-11 |
Bailey Megan D. |
EVP, Pres, Central Labs & Intl |
Ejercicio de Opciones (Venta) |
403 |
- |
- |
| 2026-02-11 |
Kliphouse Kirsten Marie |
Director |
Ejercicio de Opciones (Venta) |
897 |
- |
- |
